usually unnecessary"; however, a few studies have found discordant results when carrying out simultaneous bilateral biopsies with an increased diagnostic yield (Boyev et al., 1999; Breuer et al., 2009 and Durling et al., 2014) , suggesting bilateral temporal artery biopsies could lead to less treatment delaysand more accurate diagnoses. Key learning points: Myocarditis is a recognised complication of giant cell arteritis. The key to diagnosis here was a thorough history and an open mind with regards to his background, particularly the bilateral strokes. Investigations initially did not support GCA-associated myocarditis. But the preceding typical GCA symptoms and recent strokes raised the suspicion of a more systemic vasculitis. Working off others' diagnosis can be misleading. The very recent bilateral posterior circulation strokes and vertebral artery abnormalities were overlooked on admission due to being thoroughly worked up and disregardedas vasculitic bya tertiary stroke centre. Conflicts of interest: The authors have declared no conflicts of interest.
CLAUDICATION, CEREBRAL INFARCT AND CYCLOPHOSPHAMIDE
Jeeu Teck Sze 1 1 Rheumatology, Countess of Chester Hospital, Chester, United Kingdom Introduction: We present a severe and rare case of GCA involving the right middlecerebral artery (MCA) resulting in an ischaemic stroke. Our patient presented in 2017, before tocilizumab was approved as a treatment option in refractory GCA. Intravenous cyclophosphamide was used as a glucocorticoid-sparing agent in this patient with good response. This case contributes to our current limited evidence base in the treatment and prognosis of intracranial GCA. Case description: The patient was 75 years old when referred by his GP with a four-month history of left temporal headache, jaw claudication and weight loss in August 2017. He had type 2 diabetes and hypertension. He alsohadastroke in2015 andwassubsequentlyfoundtohaveparoxysmal atrial fibrillation so was commenced onrivaroxaban. His bloods showed ESR of 66 and CRP 18. ESR had been persistently raised for two months. Ophthalmology assessment revealed bilateral cataracts only. A clinical diagnosis of GCA was made and he was commenced onprednisolone 60mg daily. A biopsy of his left temporal artery was performed six days later and the histology showed transmural inflammation with multinucleated giant cells. His headache and jaw claudication improved with prednisolone but he was still experiencing localised temporal artery tenderness. In the last week of September 2017, he presented to the Emergency Department with a two-day history of incoordination and left arm weakness. MRI of his head showed small foci of infarcts in the right MCA territory. He had suffered an ischaemic stroke likely secondary to GCA despite being treated with high dose oral glucocorticoid. He was given three pulses of intravenous methylprednisolone followed by intravenous cyclophosphamide. Subsequent CT angiogram (CTA) confirmed the involvement of intracranial arteries -circumferential thickening of the right internal carotid artery with near complete occlusion of right cavernous and intracranial segments. There was also mural thickening involving the left vertebralartery. Hewentontohave fivemorecyclesofcyclophosphamideandresponded well to treatment. Oral methotrexate 15mg weekly was added in two weeks after the last course of cyclophosphamide. During his last clinic visit, he was taking prednisolone 2mg daily and the plan was to taper the dose downto zero over eight weeks. Discussion: Though uncommon, GCA can affect vertebrobasilar arteries causing strokes. The involvement of intracranial arteries, on the other hand, is thought to be extremely uncommon in GCA due to their increased wall thickness. There is only a limited number of intracranial GCA cases reported in the medical literature. A review of nearly 500 patients with a diagnosis of central nervous system vasculitis at the Mayo Clinic identified only two patients with convincing evidence of intracranial GCA. Our patient's MRI and CTA were reviewed in the neuroradiology multidisciplinary meeting and the consensus was that there was a near complete occlusion of the right MCA due to avasculiticprocess. Importantly, his GCA went into remission and he has not had any relapses thus far (21 months since his initial presentation). He has also improved from the stroke point of view. We have been able to reduce his prednisolone dose to aminimallevel. The use of oral or intravenous cyclophosphamide in the treatment of refractory GCA have been reported. It was found to be effective in inducing a sustained remission in a majority of patients in a series of 35 patients in Germany. However, significant adverse events were reported in one third of the patients. Our patient tolerated intravenous cyclophosphamide therapy well. He was given fluconazole and co-trimoxazole as prophylactics. He did not report any major infections or adverse events during the four-month period whenhe was on cyclophosphamide. Key learning points: This case represents a severe variant of GCA. Our patient was only referred to secondary care after being unwell for several months. It illustrates the importance of promptly initiating investigations and treatment whenGCA is suspected. This case demonstrates the importance of following up with patients closely as well as working closely with the multispecialty team in managing patients with GCA. Conflicts of interest: The authors have declared no conflicts of interest. Introduction: Giant cell arteritis is a vasculitis which predominantly affects the carotid artery and its extra-cranial branches. Its classical presentation is that of headache with scalp tenderness but should be considered in anyone over the age of fifty years with transient visual symptoms, unexplained facial pain and/or jaw claudication. As a systemic vasculitis, clinical signs may vary, however respiratory complications compared to other vasculitides are uncommon. We presenta case of newonset pleural effusion as apresenting featureof giant cell arteritis. Case description: A seventy-year-old man previously fit and well was referred to respiratory clinic after a CXR done for ongoing non-productive dry cough showed a small right sided pleural effusion. Accompanying symptoms included a reduced appetite with around 6kg weight loss over the preceding month. His past medical history included a TIA, occasional palpitations and prostatectomy for a benign prostatic hypertrophy. His only regular medication was aspirin. He never smoked and was a retired communications engineer with no known history of asbestos exposure. On examination he had no peripheral stigmata of respiratory disease and chest auscultation was clear. He had routine blood tests which revealed a normocytic anaemia (Hb 108), an elevated CRP (145.6) and elevated ESR (131).LFTs were mildly deranged and U&Es were unremarkable. A subsequent CT scan was arranged which confirmed a small right sided pleural effusion and a small pericardial effusion. General soft tissue oedema surrounding the upper abdominal organs was also noted. There was no evidence of malignancy. For workup of anaemia, he underwent a gastroscopy and colonoscopy. Gastroscopy was normal and colonoscopy revealed a single pedunculated sigmoid polyp which histologically was an adenoma. An echocardiogram showed no evidence of heart failure. 24 hour ECG telemetry was arrangeddue to palpitations but this was essentially normal. The patient eventually developed a bilateral temporal headache and malaise. He was commenced on 40mg prednisolone. While awaiting temporal artery biopsy he subsequently developed jaw claudication and prednisolone was increased to 60mg a day. Biopsy confirmed giant cell arteritis. All his symptoms improved with steroids including fatigue, headaches, cough and he started to regain weight. Similarly biochemically all abnormalities normalised. A subsequent CXR showed complete resolution of the pleural effusion. Discussion: Giant cell arteritis (GCA), like all systemic vasculitides, has been recognised to often involve the respiratory system. This has been reported to be in as high as 31% of patients with GCA. Notably, a persistent dry cough associated with fever has been recognised to be the most common respiratory symptom and has also been found to be one of the more atypical initial manifestations of GCA. This correlates with raised inflammatory markers and both of which were seen in the subject of this report. Although presence of a cough does not appear to correlate with other clinical symptoms of this particular vasculitis, it has been shown to markedly improve in response to steroids, suggesting its aetiology is GCA driven. The presence of pleural effusion however is far less common and indeed is exceptionally rare to be part of the initial presentation of GCA. Thereare ahandfulof cases in the literature, and most often the finding of pleural effusion coexists with more typical signs of GCA. The pleural effusion in our case was relatively small and was not considered safe for diagnostic aspiration. Rapid and complete resolution of an otherwise persistent pleural effusion with commencement of prednisolone points to GCA as the primary cause of the pleural effusion. Key learning points: This case shows that GCA can rarely present as cough and pleural effusion which may precede more typical clinical features often associated with GCA. The importance of recognition of GCA as the cause of pulmonary manifestations in such cases is that appropriate steroid therapy can induce complete resolution and avoid the need for further, potentially harmful invasive investigations. Our case further highlights the complexity of large vessel vasculitis such as GCA due to their varied presentation and symptoms. In patients with an unexplained weight loss, aside from malignancy the differential diagnoses shouldinclude vasculitis. Conflicts of interest: The authors have declared no conflicts of interest.
DRY COUGH AND PLEURAL EFFUSION AS PRESENTING FEATURES OF GIANT CELL ARTERITIS

GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: TWO SIDES OF THE SAME COIN IN AN ELDERLY FEMALE?
Hira Ghuman 1,2 and Muditha Samaranayaka 1 1 Rheumatology, Salford Royal NHS Foundation Trust, Manchester, United Kingdom, and 2 Department of Rheumatology, University of Manchester, Manchester, United Kingdom Introduction: Large vessel vasculitis (LVV) is a heterogeneous group of conditions, comprising of giant cell arteritis (GCA) and Takayasu arteritis (TAK). The American College of Rheumatologists (ACR) criteria provides a scoring system based on age, symptoms, and clinical examination findings, investigations to reach a diagnosis of either GCA or TAK. Similarly, European League Against Rheumatism (EULAR) recommendations discuss various imaging modalities in visualising vascular inflammation. Management is typically glucocorticoids, but for relapsing disease the challenge is finding suitable glucocorticoid-sparing agents. Here we describe a case of LVV presenting with great diagnostic complexity, discussing diagnostic modalities, treatment options and complications of therapy. Case description: A 64-year-old female was referred to rheumatology clinic following extensive negative investigations, apart from on-going inflammatory response under gastroenterology for unexplained weight loss forover ayear. Further history revealed lower limb cramps, fatigue and frontal headaches. She did not report any jaw claudication or visual disturbances but had atypical neck pain. As the main carer for her mother with dementia all these symptoms led to significant functional impairment and a great deal of anxietyforthe patient. Under the gastroenterologists, she has had negative upper and lower GI endoscopies, CT thorax, abdomen and pelvis, labelled white cell scan and isotope bone scan in addition to a comprehensive septic screen including spinal imaging. A diagnosis of systemic vasculitis was suspected. ANCA screen was negative. Patient declined a superficial temporal artery biopsy. A FDG PET scanconfirmed increased activityinmediumand large sizedvessels, such as the common carotids, descending thoracic aorta, vertebral arteries, andfemoral arteries.Sitesof metabolic hypersignalwere consistent with large vessel vasculitis. Previous CT angiography was reviewed once again. No evidence of TAK was identified. GCA-LVV was decided as the most likely diagnosis. The patient responded well to induction oral steroids with marked andrapidimprovementintheinflammatoryresponse.Duringtheweaning down of steroids, the weight loss and the inflammatory response recurred. Steroid sparing therapy was added on. Azathioprine was shortly discontinued owing to deranged liver function tests despite normal TPMT levels. Methotrexate was stopped as it caused suspected acute pneumonitis. Oral bisphosphonates were not tolerated and she was listed for IV. Shortly after, she suffered a low trauma fracture neck of femur which caused fat emboli leading to a dense stroke. She recovered gradually with anticoagulation. Currently she is being screened for SC tocilizumab. Discussion: Diagnosing LVV can be challenging owing to non-specific symptoms at presentation. Although our patient's presentation of fatigue, weight loss and worsening inflammatory markers were reflective of a vasculitis-like pathology from the onset, confirming the exact diagnosis was far from straightforward. LVV has countless clinical manifestations with new onset headaches being the most predominant. Limb claudication, another presenting symptom, is described in literature as a clinical manifestation of LVV in 5-15% of cases. The patient's complaint of neck pain is also a feature associated with external carotid artery disease. Various imaging modalities, including MRI, CT angiogram, and FDG PET scans have been implicated in the diagnosis of LVV. Currently, no i42 27 September 2019 POSTER PRESENTATIONS
